Koley Manankar, Han Jianlin, Soloshonok Vadim A, Mojumder Subhajit, Javahershenas Ramin, Makarem Ata
CSIR-Central Glass & Ceramic Research Institute Kolkata India.
College of Chemical Engineering, Nanjing Forestry University Nanjing China.
RSC Med Chem. 2023 Oct 20;15(1):10-54. doi: 10.1039/d3md00511a. eCollection 2024 Jan 25.
Many researchers around the world are working on the development of novel anticancer drugs with different mechanisms of action. In this case, coumarin is a highly promising pharmacophore for the development of novel anticancer drugs. Besides, the hybridization of this moiety with other anticancer pharmacophores has emerged as a potent breakthrough in the treatment of cancer to decrease its side effects and increase its efficiency. This review aims to provide a comprehensive overview of the recent development of coumarin derivatives and their application as novel anticancer drugs. Herein, we highlight and describe the largest number of research works reported in this field from 2015 to August 2023, along with their mechanisms of action and structure-activity relationship studies, making this review different from the other review articles published on this topic to date.
世界各地的许多研究人员都在致力于开发具有不同作用机制的新型抗癌药物。在这种情况下,香豆素是开发新型抗癌药物极具前景的药效基团。此外,该部分与其他抗癌药效基团的杂化已成为癌症治疗中的一个有力突破,可减少其副作用并提高其疗效。本综述旨在全面概述香豆素衍生物的最新进展及其作为新型抗癌药物的应用。在此,我们重点介绍并描述了2015年至2023年8月该领域报道的数量最多的研究工作,以及它们的作用机制和构效关系研究,使本综述有别于迄今为止发表的关于该主题的其他综述文章。